BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 36043623)

  • 1. [From community pharmacies to big pharmacy chains: private provision of medicines, health system, and financialization of the Brazilian retail pharmacy market].
    Mattos LV; Silva RMD; Silva FDRPD; Luiza VL
    Cad Saude Publica; 2022; 38Suppl 2(Suppl 2):e00085420. PubMed ID: 36043623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Analysis of financial statements from companies in the Brazilian health sector (2009-2015): concentration, centralization of capital, and expressions of financialization].
    Andrietta LS; Monte-Cardoso A
    Cad Saude Publica; 2022; 38Suppl 2(Suppl 2):e00006020. PubMed ID: 36043616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Financialization, accumulation, and shareholding changes in companies and corporate groups in the Brazilian health sector].
    Mattos LV; Carvalho EMCL; Barbosa DVS; Bahia L
    Cad Saude Publica; 2022; 38Suppl 2(Suppl 2):e00175820. PubMed ID: 36043625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Entry and competition of retail pharmacies: A case study of OTC drugs sales and ownership deregulation1.
    Bilka M; Duarte AP; Lábaj M
    Ceska Slov Farm; 2023; 72(1):11-20. PubMed ID: 36858976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contracting retail pharmacies as a source of essential medicines for public sector clients in low- and middle-income countries: a scoping review of key considerations, challenges, and opportunities.
    Kaplan WA; Cellini CM; Eghan K; Pilz K; Harrison D; Wirtz VJ
    J Pharm Policy Pract; 2023 May; 16(1):60. PubMed ID: 37131256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Early achievements of the Danish pharmaceutical industry--8. Lundbeck].
    Grevsen JV; Kirkegaard H; Kruse E; Kruse PR
    Theriaca; 2016; (43):9-61. PubMed ID: 27491172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacy Benefit Managers: History, Business Practices, Economics, and Policy.
    Mattingly TJ; Hyman DA; Bai G
    JAMA Health Forum; 2023 Nov; 4(11):e233804. PubMed ID: 37921745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stakeholders' expectations and perceived effects of the pharmacy ownership liberalization reform in Sweden: a qualitative interview study.
    Wisell K; Winblad U; Sporrong SK
    BMC Health Serv Res; 2016 Aug; 16(1):379. PubMed ID: 27519573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in pharmaceutical retail market and regional inequality of community pharmacists accessibility in mainland China: a retrospective cross-sectional study.
    Feng Z; Ye Y; Ye H; Tang Z
    BMJ Open; 2022 Nov; 12(11):e063739. PubMed ID: 36410821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Health plans and insurance: financialization of companies and economic groups that control the private healthcare scheme in Brazil].
    Sestelo JAF; Tavares LR; Silva MSMD
    Cad Saude Publica; 2022; 38Suppl 2(Suppl 2):e00075621. PubMed ID: 36043619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retail pharmacy prescription medicines' availability, prices and affordability in Eswatini.
    Shambira G; Suleman F
    Afr J Prim Health Care Fam Med; 2021 Sep; 13(1):e1-e11. PubMed ID: 34636605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Financialization of the health sector in Brazil: theoretical and methodological challenges to the investigation of companies and business groups].
    Bahia L; Poz MD; Levcovitz E; Costa LS; Mattos LV; Andrietta LS; Monte-Cardoso A; Travassos C
    Cad Saude Publica; 2022; 38Suppl 2(Suppl 2):e00004420. PubMed ID: 36043615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [An analysis of the pharmaceuticals market in Vietnam].
    Simonet D
    Sante; 2001; 11(3):155-60. PubMed ID: 11641078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The Korean Pharmaceutical Industry and the Expansion of the General Pharmaceuticals Market in the 1950-1960s].
    Sihn KH
    Uisahak; 2015 Dec; 24(3):749-81. PubMed ID: 26819439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary health care policy and vision for community pharmacy and pharmacists in Colombia.
    Amariles P; Ceballos M; González-Giraldo C
    Pharm Pract (Granada); 2020; 18(4):2159. PubMed ID: 33294064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The 2017 deregulation of pharmacies in Italy: Introducing non-pharmacist ownership.
    Gallone EL; Ravetto Enri L; Pignata I; Baratta F; Brusa P
    Health Policy; 2020 Dec; 124(12):1281-1286. PubMed ID: 32994057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Balancing medicine prices and business sustainability: analyses of pharmacy costs, revenues and profit shed light on retail medicine mark-ups in rural Kyrgyzstan.
    Waning B; Maddix J; Soucy L
    BMC Health Serv Res; 2010 Jul; 10():205. PubMed ID: 20626904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Foreign capital and structural change in the Brazilian private health services market].
    Kamia FD; Vargas MA
    Cad Saude Publica; 2023; 39(9):e00171222. PubMed ID: 37792818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors affecting bargaining outcomes between pharmacies and insurers.
    Brooks JM; Doucette W; Sorofman B
    Health Serv Res; 1999 Apr; 34(1 Pt 2):439-51. PubMed ID: 10199687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From symbiosis to independence: Investigating changes in the relationship between general practitioners' presence and pharmacies' market size in Slovakia.
    Kališ R
    Health Policy; 2024 May; 143():105040. PubMed ID: 38503174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.